Spencer R. Berthelsen - Jul 15, 2021 Form 4 Insider Report for IONIS PHARMACEUTICALS INC (IONS)

Role
Director
Signature
By: Patrick R. O'Neil, attorney-in-fact For: Spencer R. Berthelsen
Stock symbol
IONS
Transactions as of
Jul 15, 2021
Transactions value $
$0
Form type
4
Date filed
7/19/2021, 08:13 PM
Previous filing
Jul 6, 2021
Next filing
Jun 9, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IONS Common Stock Options Exercise $0 +5.33K +5.28% $0.00 106K Jul 15, 2021 Direct F1
transaction IONS Common Stock Options Exercise $0 +889 +0.84% $0.00 107K Jul 15, 2021 Direct F1
transaction IONS Common Stock Options Exercise $0 +666 +0.62% $0.00 108K Jul 15, 2021 Direct F1
transaction IONS Common Stock Options Exercise $0 +1.78K +1.65% $0.00 110K Jul 15, 2021 Direct F1
holding IONS Common Stock 70 Jul 15, 2021 by Daughter F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IONS Restricted Stock Unit Options Exercise $0 -5.33K -28.92% $0.00 13.1K Jul 15, 2021 Common Stock 5.33K $0.00 Direct F3, F4
transaction IONS Restricted Stock Unit Options Exercise $0 -889 -6.78% $0.00 12.2K Jul 15, 2021 Common Stock 889 $0.00 Direct F3, F5
transaction IONS Restricted Stock Unit Options Exercise $0 -666 -5.45% $0.00 11.6K Jul 15, 2021 Common Stock 666 $0.00 Direct F3, F5
transaction IONS Restricted Stock Unit Options Exercise $0 -1.78K -15.39% $0.00 9.78K Jul 15, 2021 Common Stock 1.78K $0.00 Direct F3, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Acquired pursuant to vesting and release of shares pursuant to a Restricted Stock Unit Award.
F2 The reporting person disclaims beneficial ownership of all securities held by his daughter, and this report should not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
F3 Each Restricted Stock Unit represents a contingent right to receive one share of Ionis common stock, or its equivalent cash value.
F4 Restricted Stock Units vest 100% on either the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders of the Company, whichever occurs earlier, and are delivered to the reporting person on the July 15th following the vesting date. Upon vesting, the Restricted Stock Units will be paid in whole shares of Ionis common stock or cash as may be determined by the Company.
F5 Restricted Stock Units vest in four equal annual installments and are delivered to the reporting person on the July 15th following the vesting date. Upon vesting, the Restricted Stock Units will be paid in whole shares of Ionis common stock or cash as may be determined by the Company.